{"slug":"origene","name":"Origene","url":"https://www.gp-intel.com/company/origene","sector":"Healthcare","country":"China","hq_city":null,"website":null,"founded_year":null,"ipo_year":null,"status":"exited","current_owner":null,"current_holder":{"name":"Vcanbio Cell & Gene Engineering","names":["Vcanbio Cell & Gene Engineering"],"since_year":2021,"basis":"trade_sale"},"ownership_periods":2,"ownership":[{"owner":"Cathay Capital","fund":"Cathay Capital Midcap I","fund_vintage":2014,"entry_year":2015,"exit_year":2021,"is_exit":true,"deal_type":"Trade Sale","buyer":"Vcanbio Cell & Gene Engineering","moic":null,"sector":"Healthcare"},{"owner":"Merieux Equity Partners","fund":"Mérieux Innovation 1","fund_vintage":2014,"entry_year":2015,"exit_year":2016,"is_exit":true,"deal_type":"Trade Sale","buyer":"Shanghai Aoyuan Investment Management Co., Ltd.","moic":null,"sector":"Healthcare"}],"source":"gp-intel.com","license":"CC-BY-4.0","updated_at":"2026-04-21T14:45:54.545Z"}